Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728194 · ClinicalTrials.gov registry record · Phase 4
Emotional and Cognitive Control in Late-Onset Depression
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 121
- Enrollment target
NCT01728194 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 121 participants.
The verdict
NCT01728194, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 121 participants
- Enrollment target
Study Summary
This study may help identify how abnormalities in brain systems that control the ability to ignore irrelevant information may contribute to the development of depression in older adults.
Interventions
- DRUG Escitalopram
- OTHER Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01728194
The ClinicalTrials.gov registry entry for NCT01728194 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT01728194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01728194 about?
NCT01728194 is a clinical study titled "Emotional and Cognitive Control in Late-Onset Depression". This study may help identify how abnormalities in brain systems that control the ability to ignore irrelevant information may contribute to the development of depression in older adults.
What is the current status of trial NCT01728194?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 121 participants. The study started on 2012-07. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT01728194?
The interventions under investigation include: Escitalopram (DRUG), Magnetic Resonance Imaging (OTHER).
Who is sponsoring clinical trial NCT01728194?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.